Misread Women’s Health Initiative data sidelined hormone therapy and menopause education, according to Mary Jane Minkin, MD, ...

MsFLASH, an NIH-funded menopause clinical trials network active from 2008 to 2022, ran 5 trials with 9 interventions and 8 ...

Night sweats in a midlife patient who also reported hot flashes usually reflect menopause, and clinicians who attributed the ...

For primary care clinicians, counseling patients on what to expect from elinzanetant, both its side effects and how quickly ...

Between 40% and 60% of women reported brain fog or forgetfulness during the menopause transition, according to Pauline M.

Misread Women’s Health Initiative data sidelined hormone therapy and menopause education, according to Mary Jane Minkin, MD, FACOG.

Late recurrence, high-risk features, and treatment failure can signal midlife night sweats aren’t menopause, according to Cheryl Cox Kinney, MD.

Distress, not low libido alone, defines HSDD, which requires a biopsychosocial evaluation, according to Holly N. Thomas, MD, ...

Working with the NIH Office of Research on Women’s Health, the division is directed to increase scientific review of understudied women’s health conditions, advance and coordinate research, including ...

Higher physical activity frequency showed a statistically significant inverse association with total perimenopause symptom burden in a fully adjusted analysis (β = −0.57, P < 0 ...

Antenatal risk assessment and structured postpartum follow-up are central to managing cardiovascular risk in pregnancy, ...

Real-world sleep data on fezolinetant (Veozah) gave ob-gyns an additional, evidence-based point to raise when counseling ...